Drug Search Results
More Filters [+]

Fenbendazole

Alternative Names: fenbendazole
Latest Update: 2023-10-05
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Bangladesh | European Medicines Agency | Hong Kong | India | Malaysia | Norway | Pakistan | Poland

Approved Indications: None

Known Adverse Events: None

Company: Dr Taufiq Binjemain
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Fenbendazole

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ACTRN12623001164684

N/A

Not yet recruiting

Nose Cancer

2025-06-30

Recent News Events